Stefan Schildknecht
- Biochemistry top 2%
- Eicosanoids and Hypertension Pharmacology 11
- Developmental Neuroscience top 5%
- Physiology top 5%
- Nitric Oxide and Endothelin Effects 23
- Alzheimer's disease research and treatments 6
- Neurology top 5%
- Parkinson's Disease Mechanisms and Treatments 13
- Neurology top 5%
- Parkinson's Disease Mechanisms and Treatments 13
-
- Inflammatory mediators and NSAID effects 9
-
- Neuroscience and Neuropharmacology Research 8
-
- Mitochondrial Function and Pathology 6
- Pluripotent Stem Cells Research 6
- Co-authors
- Marcel LeistMarkus BachschmidVolker UllrichAndreas DaiberDominik PöltlCordula HirschChristiaan KarremanDiana Scholz
- Journals
- Archives of Toxicology (6 papers)Biochemical and Biophysical Research Communications (5 papers)Redox Biology (4 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Stefan Schildknecht
66 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 135
- Biochemistry 254
- Developmental Neuroscience 140
- Physiology 747
- Neurology 434
- Neurology 219
Countries citing papers authored by Stefan Schildknecht
This map shows the geographic impact of Stefan Schildknecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Schildknecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Schildknecht more than expected).
Fields of papers citing papers by Stefan Schildknecht
This network shows the impact of papers produced by Stefan Schildknecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Schildknecht. The network helps show where Stefan Schildknecht may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stefan Schildknecht, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 10 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 1 | |
| 6 | 2019 | 96 | |
| 7 | 2017 | 78 | |
| 8 | 2015 | 53 | |
| 9 | 2015 | 37 | |
| 10 | 2014 | 80 | |
| 11 | 2013 | 59 | |
| 12 | 2012 | 30 | |
| 13 | 2012 | 11 | |
| 14 | 2012 | 13 | |
| 15 | 2010 | 93 | |
| 16 | 2009 | 23 | |
| 17 | 2009 | 6 | |
| 18 | Vor- und Nachdenkliches ... zum wahren Erfolg des 3R-Prinzips | 2008 | 1 |
| 19 | 2008 | 27 | |
| 20 | 2008 | 17 |
About Stefan Schildknecht
Stefan Schildknecht is a scholar working on Biochemistry, Physiology and Developmental Neuroscience, having authored 68 papers that have together received 2.8k indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (23 papers), Parkinson's Disease Mechanisms and Treatments (13 papers), Eicosanoids and Hypertension Pharmacology (11 papers), Inflammatory mediators and NSAID effects (9 papers), Neuroscience and Neuropharmacology Research (8 papers), Mitochondrial Function and Pathology (6 papers), Pluripotent Stem Cells Research (6 papers) and Alzheimer's disease research and treatments (6 papers). The work is most often cited by research in Biochemistry (254 citations), Developmental Neuroscience (140 citations) and Physiology (747 citations). Stefan Schildknecht has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Marcel Leist, Markus Bachschmid, Volker Ullrich, Andreas Daiber, Dominik Pöltl, Cordula Hirsch, Christiaan Karreman, Diana Scholz, Malte Drescher and Regina Pape. Their work appears in journals such as Archives of Toxicology, Biochemical and Biophysical Research Communications, Redox Biology, Free Radical Biology and Medicine and Antioxidants and Redox Signaling.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.